Tirzepatide price in 2026: prescription prices and research-grade costs

Lilly's published prices for Mounjaro and Zepbound, set apart from what research-grade tirzepatide costs per mg at US suppliers, as checked on November 17, 2026.

Buying guide8 min read

Key takeaway

Lilly lists Mounjaro at $1,112.16 for a 28-day supply. Its savings card prices start at $25 with commercial coverage, and Zepbound self-pay starts at $299, all by prescription. Research-grade tirzepatide is a laboratory reagent, not a medicine: US research suppliers listed it at $2.17 to $10.00 per mg on November 17, 2026. Vitrapep lists a 10 mg vial at $74.99, for laboratory research use only.

At a glance

Article typeBuying guide
Main guideTirzepatide: complete guide
Regulatory statusFDA-approved“Tirzepatide is the first FDA-approved dual agonist” (Tirzepatide: complete guide)
ClassMetabolic & weight
Body systemsEndocrine & metabolism
Studies cited2 in this article · 10 across 15 articles on Tirzepatide
ProductTirzepatide product page

Tirzepatide price depends on which product the question is about. Mounjaro and Zepbound are FDA-approved prescription medicines, and Eli Lilly publishes their list, savings and self-pay prices. Research-grade tirzepatide is something else: a lyophilized reagent sold for laboratory research use only, priced per vial and per mg. This page sets out both sets of numbers as they stood on November 17, 2026, and keeps the two categories apart.

Quick answer: As published by Lilly on November 17, 2026, Mounjaro lists at $1,112.16 for a 28-day supply. The Lilly pages we checked list self-pay and savings prices for Zepbound, not a list price for the single-dose Pen. Zepbound self-pay starts at $299 per fill. Research-grade tirzepatide, a different product category, listed at $39.99–$199.99 per vial at US research suppliers. Vitrapep lists 10 mg at $74.99.

Two different categories, two different prices

Tirzepatide is a 39-amino-acid peptide with two non-coded amino acids (Aib) and a C20 fatty diacid attached through a linker at lysine 20. It acts at both the GIP and GLP-1 receptors (Coskun et al., 2018). The name covers two kinds of product:

  • Prescription medicines. Mounjaro and Zepbound are FDA-approved, made and tested under FDA drug manufacturing rules, and dispensed by a pharmacy on a prescription. They have list prices, insurance rules and manufacturer savings programs.
  • Research reagents. Research-grade tirzepatide is a lyophilized powder sold for laboratory work. FDA has not reviewed it as a drug. It is for laboratory research use only, not for human or veterinary use.

One is not a substitute for the other, and the prices below are not a comparison. FDA has warned companies that sold tirzepatide and other GLP-1 products labeled “for research purposes” or “not for human consumption” directly to consumers, and it urges consumers not to purchase them (FDA, 2026). Our semaglutide price page draws the same line for semaglutide.

The approved tirzepatide products

FDA records show two brand names, each sold as single-dose pens, vials and a KwikPen:

  • Mounjaro (NDA 215866) was first approved on May 13, 2022 (FDA, Drugs@FDA). Its label covers glycemic control in type 2 diabetes, for adults and children 10 and older, and cardiovascular risk reduction in high-risk adults with type 2 diabetes (Mounjaro label, DailyMed).
  • Zepbound (NDA 217806) was first approved on November 8, 2023 (FDA, Drugs@FDA). Its label covers reducing excess body weight and keeping it off long term in adults with obesity, or overweight with a weight-related condition, and moderate to severe obstructive sleep apnea in adults with obesity (Zepbound label, DailyMed).

Mounjaro and Zepbound prices as Lilly publishes them

A list price is the price a manufacturer sets before discounts or rebates. Insurance and savings programs change what a person pays. These are the figures on Lilly’s Mounjaro and Zepbound sites, as of November 17, 2026:

Table 1

Lilly list, savings and self-pay prices for tirzepatide medicines, as published November 17, 2026

Product List price Lilly savings or self-pay price
Mounjaro$1,112.16 for a 28-day supplyAs little as $25 per fill with commercial coverage; as low as $499 per 1-month fill without it
Zepbound single-dose PenNot shown on the Lilly pages checkedAs little as $25 per fill with commercial coverage; as low as $499 per 1-month fill without it
Zepbound KwikPenNot shown on the Lilly pages checkedSelf-pay $299 to $699 per 1-month fill, by strength; $299, $399 or $449 with Lilly’s KwikPen card
Zepbound vialsNot shown on the Lilly pages checkedSelf-pay from $299 per 1-month fill

Sources: Lilly’s Mounjaro FAQ, Mounjaro savings page and Zepbound savings page, all read November 17, 2026. Lilly states that these cards expire and savings end on December 31, 2026. The $499 offers apply to commercially insured patients whose plan does not cover the medicine. Mounjaro self-pay is offered through LillyDirect, with no price on the page checked. A prescription is required.

Two more points from Lilly’s own pages:

  • Card caps. Annual card savings are capped at $1,950 for Mounjaro with coverage, $8,411 for Mounjaro without coverage and $1,300 for the Zepbound Pen with coverage (Lilly, 2026b; Lilly, 2026c).
  • Medicare. Lilly says eligible Medicare Part D patients prescribed Zepbound for weight management can get it through the Medicare GLP-1 Bridge for no more than $50 a month (Lilly, 2026c).

Research-grade tirzepatide prices

Research-grade tirzepatide is priced like any research peptide: per vial and per mg. We checked US supplier product pages on November 17, 2026, and recorded the listed single-vial price. Prices exclude shipping, codes and pack discounts.

Table 2

Research-grade tirzepatide prices at US suppliers, checked November 17, 2026

Supplier Vial size Listed price Price per mg
Zeptix Labs (listed as GLP-2 T)10 mg$79.99$8.00
Zeptix Labs (listed as GLP-2 T)30 mg$110.00$3.67
Purely Peptides10 mg$74.99$7.50
Purely Peptides30 mg$89.99$3.00
Purely Peptides60 mg$129.99$2.17
PS Peptides10 mg$54.99$5.50
PS Peptides30 mg$114.99$3.83
PS Peptides60 mg$199.99$3.33
American Peptides (listed as AP-TRZ-2, code LY3298176)10 mg$100.00$10.00
Peptide Giants (listed as TRZ-2)10 mg$39.99$4.00
Vitrapep10 mg$74.99$7.50

Sources: supplier product pages listed in the references, read November 17, 2026. Price per mg is the listed price divided by the vial size. Zeptix Labs had a buy-one-get-one offer on 10 mg. PS Peptides size prices are from the store’s own data for the listing. American Peptides gives a research code and CAS number, not the name tirzepatide. Peptide Giants names no compound and priced only 10 mg. All are sold for laboratory research use only.

Across the listings we checked, research-grade tirzepatide ran from $39.99 to $199.99 per vial and from $2.17 to $10.00 per mg. Larger vials cost less per mg because filling, labeling and lot testing cost about the same at any size.

What moves research tirzepatide prices

The levers are the same ones covered in our peptide prices explainer:

  • Synthesis length. Peptides are built one amino acid at a time, and each coupling step loses some yield. A 39-residue chain costs more per mg than a short one (Verlander, 2007).
  • Chemistry. The two Aib residues and the fatty diacid side chain each add synthesis and purification work (Coskun et al., 2018).
  • Purity and testing. HPLC purity and mass spectrometry identity from an outside laboratory, ideally one accredited to ISO/IEC 17025, cost money per lot.
  • Promotions. Buy-one-get-one offers and sale prices change the effective price from week to week.

Red flags in very cheap listings

A low price is not proof of a problem, but it leaves less room for the steps that confirm what is in the vial. Look closer at these signs:

  • No compound name. A code such as TRZ-2 is fine if the page or certificate also names the compound or gives its CAS number. The TRZ-2 page we checked did neither, so identity could not be checked against the label.
  • A price far below the range. The lowest vial price in Table 2 was $39.99 for 10 mg. Below that, ask for the lot’s test report first.
  • Brand-name comparisons. A research listing that names Mounjaro or Zepbound, or prices itself against them, is pitching a reagent as a medicine.
  • Human-use language. FDA has acted against GLP-1 products sold under research labels with dosing instructions for consumers (FDA, 2026). A research listing should carry none.
  • No lot-specific certificate. A credible certificate names the lot, the laboratory, the test date, HPLC purity and a mass spectrometry identity result. Our guide to reading a certificate of analysis walks through each field.

What Vitrapep charges for tirzepatide

Vitrapep lists tirzepatide as a 10 mg lyophilized vial at $74.99, or $7.50 per mg. Store prices may still change before launch. It is a research reagent, sold for laboratory research use only and not for human or veterinary use. It is not Mounjaro or Zepbound, and it is not a substitute for any prescription medicine. For sourcing, see where to buy tirzepatide. For background, see our tirzepatide guide and tirzepatide vs semaglutide.

Tirzepatide

Lyophilized Lot documentation Research use only

Specifications and the current lot’s test documentation for the tirzepatide sold for laboratory research.

View tirzepatide specifications

Frequently asked questions about tirzepatide price

What is the list price of Mounjaro and Zepbound?

As of November 17, 2026, Lilly gave the current list price of Mounjaro as $1,112.16 for a 28-day supply (Lilly, 2026a). The Lilly pages we checked list self-pay and savings prices for Zepbound, not a list price for the single-dose Pen.

What does tirzepatide cost without insurance?

Lilly’s Zepbound self-pay prices start at $299 per fill of the KwikPen or vials, and a prescription is required. KwikPen fills run $299 to $699 by strength, or $299 to $449 with Lilly’s KwikPen card (Lilly, 2026c).

Is research-grade tirzepatide the same as Mounjaro or Zepbound?

No. Mounjaro and Zepbound are FDA-approved prescription medicines. Research-grade tirzepatide is a laboratory reagent that FDA has not reviewed as a drug. It is for laboratory research use only, not for human or veterinary use, and not a substitute for any prescription medicine.

How much does research-grade tirzepatide cost per mg?

At the US research suppliers we checked on November 17, 2026, listed prices ran from $2.17 to $10.00 per mg, depending on supplier and vial size. Vitrapep lists 10 mg at $74.99, or $7.50 per mg.

What to know now

  • Mounjaro lists at $1,112.16 for a 28-day supply. The Lilly pages checked give no Zepbound Pen list price.
  • Savings and self-pay prices are lower. From $25 with commercial coverage; Zepbound self-pay from $299. All require a prescription.
  • Lilly’s cards end December 31, 2026. Zepbound reimbursement claims are due by March 31, 2027.
  • Research-grade tirzepatide is a different category. It is a laboratory reagent at $2.17 to $10.00 per mg, not for human or veterinary use.
  • Vitrapep lists 10 mg at $74.99. That is $7.50 per mg, within the research supplier range.

What we’re watching

First, December 31, 2026, when Lilly’s Mounjaro and Zepbound savings cards are set to expire. Second, the savings and self-pay terms Lilly sets for 2027. Third, FDA enforcement against GLP-1 products sold to consumers under research labels, which FDA last updated on October 1, 2026.

Also in the library

More for endocrine & metabolism

All 38 compounds for endocrine & metabolism

Sources: Coskun 2018, Molecular Metabolism; U.S. Food and Drug Administration 2026, FDA’s concerns with unapproved GLP-1 drugs used for weight loss; U.S. Food and Drug Administration. (n.d.). Drugs@FDA: NDA 215866 (Mounjaro) . Retrieved November 17, Drugs@FDA: NDA 215866 (Mounjaro); U.S. Food and Drug Administration. (n.d.). Drugs@FDA: NDA 217806 (Zepbound) . Retrieved November 17, Drugs@FDA: NDA 217806 (Zepbound); Eli Lilly and Company 2026, Mounjaro (tirzepatide) injection: Prescribing information; Eli Lilly and Company 2026, Zepbound (tirzepatide) injection: Prescribing information; Lilly USA 2026a, Mounjaro frequently asked questions; Lilly USA 2026b, Mounjaro savings and support; Lilly USA 2026c, Zepbound savings and insurance options; Verlander 2007, International Journal of Peptide Research and Therapeutics; International Organization for Standardization 2017; Zeptix Labs. (n.d.). GLP-2 T (Tirzepatide) [Product page]. Retrieved November 17, GLP-2 T (Tirzepatide); Purely Peptides. (n.d.). Tirzepatide 30mg [Product page]. Retrieved November 17, Tirzepatide 30mg; PS Peptides. (n.d.). Tirzepatide (1 vial) [Product page]. Retrieved November 17, Tirzepatide (1 vial); American Peptides. (n.d.). AP-TRZ-2 research reference peptide (LY3298176) [Product page]. Retrieved November 17, AP-TRZ-2 research reference peptide (LY3298176); Peptide Giants. (n.d.). TRZ-2 [Product page]. Retrieved November 17, TRZ-2. All 16 citations

Back to the research library

References

  1. Coskun, T., Sloop, K. W., Loghin, C., et al. (2018). LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept. Molecular Metabolism, 18, 3–14. https://doi.org/10.1016/j.molmet.2018.09.009
  2. U.S. Food and Drug Administration. (2026, October 1). FDA’s concerns with unapproved GLP-1 drugs used for weight loss. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
  3. U.S. Food and Drug Administration. (n.d.). Drugs@FDA: NDA 215866 (Mounjaro). Retrieved November 17, 2026, from https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=215866
  4. U.S. Food and Drug Administration. (n.d.). Drugs@FDA: NDA 217806 (Zepbound). Retrieved November 17, 2026, from https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=217806
  5. Eli Lilly and Company. (2026). Mounjaro (tirzepatide) injection: Prescribing information (Revised 8/2026). DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0
  6. Eli Lilly and Company. (2026). Zepbound (tirzepatide) injection: Prescribing information (Revised 8/2026). DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
  7. Lilly USA. (2026a). Mounjaro frequently asked questions (CMAT-31135 06/2026). Retrieved November 17, 2026, from https://mounjaro.lilly.com/faq
  8. Lilly USA. (2026b). Mounjaro savings and support (CMAT-31122 08/2026). Retrieved November 17, 2026, from https://mounjaro.lilly.com/savings-resources
  9. Lilly USA. (2026c). Zepbound savings and insurance options (CMAT-26402 10/2026). Retrieved November 17, 2026, from https://zepbound.lilly.com/coverage-savings
  10. Verlander, M. (2007). Industrial applications of solid-phase peptide synthesis: A status report. International Journal of Peptide Research and Therapeutics, 13(1–2), 75–82. https://doi.org/10.1007/s10989-006-9075-7
  11. International Organization for Standardization. (2017). ISO/IEC 17025:2017: General requirements for the competence of testing and calibration laboratories. https://www.iso.org/standard/66912.html
  12. Zeptix Labs. (n.d.). GLP-2 T (Tirzepatide) [Product page]. Retrieved November 17, 2026, from https://zeptixlabs.com/product/glp-2-t/
  13. Purely Peptides. (n.d.). Tirzepatide 30mg [Product page]. Retrieved November 17, 2026, from https://purelypeptides.org/product/tirzepatide-30mg/
  14. PS Peptides. (n.d.). Tirzepatide (1 vial) [Product page]. Retrieved November 17, 2026, from https://pspeptides.com/product/buy-tirzepatide/
  15. American Peptides. (n.d.). AP-TRZ-2 research reference peptide (LY3298176) [Product page]. Retrieved November 17, 2026, from https://americanpeptides.us/products/ap-trz-2
  16. Peptide Giants. (n.d.). TRZ-2 [Product page]. Retrieved November 17, 2026, from https://peptidegiants.com/product/trz/